BRIEF published on 09/04/2024 at 17:50, 2 months 16 days ago Median Technologies: Promising results for the diagnosis of lung cancer Artificial Intelligence Median Technologies Lung Cancer Eyonis™ LCS Pivotal Study
BRIEF published on 09/04/2024 at 17:50, 2 months 16 days ago Median Technologies : résultats prometteurs pour le diagnostic du cancer du poumon Intelligence Artificielle Median Technologies Cancer Du Poumon Eyonis™ LCS Étude Pivot
PRESS RELEASE published on 09/04/2024 at 17:45, 2 months 16 days ago Inside Information / Other news releases Median Technologies to share positive pivotal data for eyonis™ LCS diagnostic software at IASLC 2024 World Conference on Lung Cancer. eyonis™ LCS achieves high accuracy in detecting lung cancer Median Technologies Lung Cancer Eyonis LCS IASLC 2024 Diagnostic Software
PRESS RELEASE published on 09/04/2024 at 17:45, 2 months 16 days ago Informations privilégiées / Autres communiqués Median Technologies partagera les résultats de eyonis™ LCS au WCLC 2024, montrant une précision sans précédent dans le diagnostic précoce du cancer du poumon Median Technologies Cancer Du Poumon Eyonis™ LCS WCLC 2024 Diagnostic Précoce
BRIEF published on 08/29/2024 at 17:50, 2 months 22 days ago Median Technologies : eyonis atteint les objectifs de l'étude REALITY Dépistage Median Technologies Cancer Du Poumon Eyonis™ LCS AUC
BRIEF published on 08/29/2024 at 17:50, 2 months 22 days ago Median Technologies: eyonis achieves REALITY study objectives Screening Median Technologies Lung Cancer Eyonis™ LCS AUC
PRESS RELEASE published on 08/29/2024 at 17:45, 2 months 22 days ago Informations privilégiées / Autres communiqués Median Technologies annonce que l'étude pivot REALITY évaluant eyonis™ LCS dans le dépistage du cancer du poumon répond à tous les critères d'évaluation primaire et secondaires Dépistage Median Technologies Cancer Du Poumon Eyonis LCS Étude Pivot
BRIEF published on 07/18/2024 at 18:01, 4 months 2 days ago Median Technologies dévoile des résultats semestriels et des avancées stratégiques Chiffre D'affaires Intelligence Artificielle Carnet De Commandes ICRO Eyonis™ LCS
BRIEF published on 07/18/2024 at 18:01, 4 months 2 days ago Median Technologies unveils half-year results and strategic advances Artificial Intelligence Turnover Backlog ICRO Eyonis™ LCS
PRESS RELEASE published on 07/18/2024 at 17:56, 4 months 2 days ago Inside Information / News release on accounts, results Median Technologies reports record iCRO backlog and eyonis™ LCS on-track for pivotal study readout in August. Revenue at €10.9 million, cash at €16 million. CEO to provide update via webcast on July 24, 2024 Revenue Growth Median Technologies ICRO Eyonis LCS Pivotal Study
Published on 11/21/2024 at 13:00, 22 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 22 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 22 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 22 minutes ago Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Published on 11/21/2024 at 13:00, 22 minutes ago Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension
Published on 11/21/2024 at 12:35, 47 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 7 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 24 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 6 hours 24 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 6 hours 24 minutes ago Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 17 hours 15 minutes ago Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 18 hours 2 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
